Sector valuations Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
21:00:02 25/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 292.84 USD | -0.54% |
|
+5.32% | +46.80% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 77.82x | 4.64x | -0.34x | 4.11x | 15.72x | 19.59x | -.--% | 13.98B | ||
| 33.26x | 4.44x | 1.25x | 5.97x | 17.88x | 25.02x | 0.98% | 47.97B | ||
| 34.82x | 6.36x | -36.38x | 3.35x | 14.46x | 21.84x | -.--% | 44.5B | ||
| -21.07x | 22.21x | -0.33x | 227.64x | -22.77x | -21.57x | -.--% | 43.93B | ||
| 47.27x | 8x | 0.23x | 5.47x | 29.96x | 34.48x | -.--% | 41.03B | ||
| 26.85x | 2.18x | 0.55x | 7.74x | 19.93x | 23.35x | 0.42% | 29.85B | ||
| 35.19x | 25.25x | 2.33x | 5.78x | 26.24x | 27.46x | -.--% | 17.27B | ||
| -61.04x | 30.59x | 49.61x | 9.99x | 243.78x | -1853.76x | -.--% | 15.34B | ||
| 25.79x | 2.86x | 0.75x | 2.21x | 9.6x | 14.88x | 1.04% | 15.3B | ||
| 29.25x | 1.39x | 0.28x | 1.92x | 11.79x | 13.44x | -.--% | 13.3B | ||
| -457.7x | 3x | 4.81x | 14.04x | 83.39x | 109.11x | -.--% | 12.48B | ||
| 52.55x | 4.58x | 2.75x | 8.72x | 24.76x | 29.53x | 0.44% | 11.39B | ||
| 39.55x | 4.61x | 2.31x | 4.7x | 20.11x | 32.05x | 0.56% | 10.96B | ||
| -28.91x | 8.4x | -5.86x | 76.23x | -19.12x | -18.58x | -.--% | 9.31B | ||
| 30.5x | - | -0.09x | 15.94x | 29.08x | 28.41x | -.--% | 9.18B | ||
| 23.04x | 2.43x | -20.1x | 4.59x | 12.32x | 15.7x | 0.31% | 9.14B | ||
| -19.88x | 6.8x | 1.35x | 1653.93x | -21.17x | -21.56x | -.--% | 8.14B | ||
| -20.21x | 6.98x | -6.62x | 8313.55x | -16.42x | -16.17x | -.--% | 7.84B | ||
| -12.42x | 404.55x | -0.25x | 7.93x | -12.73x | -12.54x | -.--% | 7.4B | ||
| Average | -8.70x | 30.52x | -0.20x | 545.99x | 24.57x | -81.54x | 0.2% | 19.38B | |
| Weighted average by Cap. | 4.43x | 17.38x | -2.45x | 247.55x | 22.78x | -59.89x | 0.24% |
Select your edition
All financial news and data tailored to specific country editions
















